ANTI-CCR7 RECEPTOR ANTIBODIES FOR THE TREATMENT OF CANCER
Antibodies, or antigen-binding fragment thereof, which bind to a CCR7 receptor are capable of selectively killing, impairing migration and/or blocking dissemination of tumour cells expressing a CCR7 receptor. Use of said antibodies for killing or for inducing apoptosis of said tumour is disclosed, t...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
14.05.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!